1-3 of 3
Julie K. Ritchey
Close
Sort by
Journal Articles

Conditioning with anti-CD47 and anti-CD117 plus JAK inhibition enables toxic payload-free allogeneic transplantation

Stephen P. Persaud, Aditya R. Yelamali, Julie K. Ritchey, John F. DiPersio
Journal: Blood Advances
Blood Adv bloodadvances.2023012457.
https://doi.org/10.1182/bloodadvances.2023012457
Published: 2024
Includes: Supplemental data
Journal Articles

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Daniel Cancilla, Michael P. Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Marvin J. Meyers, Peter G. Ruminski, Stephanie Christ, Ezhilarasi Chendamarai, Feng Gao, Leah Gehrs, Julie K. Ritchey, Michael Prinsen, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1379–1383.
https://doi.org/10.1182/bloodadvances.2023011653
Published: 2024
Includes: Supplemental data
Journal Articles

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

Julie O’Neal, Matthew L. Cooper, Julie K. Ritchey, Susan Gladney, Jessica Niswonger, L. Sofía González, Emily Street, Gabriel J. Haas, Alun Carter, Parmeshwar N. Amayta, Feng Gao, Byung Ha Lee, Donghoon Choi, Melissa Berrien-Elliott, Alice Zhou, Todd A. Fehniger, Mike P. Rettig, John F. DiPersio
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6009–6022.
https://doi.org/10.1182/bloodadvances.2023010032
Published: 2023
Includes: Supplemental data